Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,030.00
+135.00 (3.47%)
At close: Oct 2, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 36.4 billion as of October 2, 2026. Its market cap has decreased by -34.89% in one year.
Market Cap
36.40B
Enterprise Value
21.29B
Revenue
83.17B
Ranking
n/a
PE Ratio
39.71
Stock Price
4,030.00
ChartMarket Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 36.40B, a decrease of -47.81%. That is a compound annual growth rate of -3.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 36.40B | -36.66% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 232.78B |
| 3billion | 192.21B |
| GENINUS | 82.33B |
| GC Medical Science | 79.68B |
| Inventera | 76.77B |
| Protia | 76.38B |
| Cytogen | 74.24B |
| HLB Panagene | 56.00B |